These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 18540816)

  • 21. Editorial commentary: cerebrospinal fluid inhibitory quotients of antiretroviral drugs.
    Fletcher CV
    Clin Infect Dis; 2015 Jan; 60(2):318-20. PubMed ID: 25281611
    [No Abstract]   [Full Text] [Related]  

  • 22. HIV neuropathogenesis.
    Levy JA
    J Neurovirol; 1997 May; 3 Suppl 1():S14-5. PubMed ID: 9179783
    [No Abstract]   [Full Text] [Related]  

  • 23. Raltegravir resistance in the cerebrospinal fluid.
    Mora-Peris B; Mackie NE; Suan D; Cooper DA; Brew BJ; Winston A
    Infection; 2013 Jun; 41(3):731-4. PubMed ID: 23378293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spectrum of neurological disease in patients with discordant HIV-1 RNA levels in plasma and cerebrospinal fluid.
    Scourfield A; Waters L; Nelson M
    J Infect; 2010 Mar; 60(3):251-2. PubMed ID: 20035786
    [No Abstract]   [Full Text] [Related]  

  • 25. Cerebrospinal fluid HIV-1 escape according to different thresholds and underlying comorbidities: is it time to assess the definitions?
    Trunfio M; Pinnetti C; Focà E; Bai F; Maffongelli G; Celani L; Cinque P; Celotti A; Andreoni M; D'Arminio Monforte A; D'Ettorre G; Antinori A; Calcagno A
    AIDS; 2019 Mar; 33(4):759-762. PubMed ID: 30531317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Difference in drug resistance patterns between minor HIV-1 populations in cerebrospinal fluid and plasma.
    Bergroth T; Ekici H; Gisslén M; Hagberg L; Sönnerborg A
    HIV Med; 2009 Feb; 10(2):111-5. PubMed ID: 19200174
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical course of cardiomyopathy in HIV-infected patients with or without encephalopathy related to the myocardial expression of tumour necrosis factor-alpha and nitric oxide synthase.
    Barbaro G; Di Lorenzo G; Soldini M; Giancaspro G; Grisorio B; Pellicelli AM; D'Amati G; Barbarini G;
    AIDS; 2000 May; 14(7):827-38. PubMed ID: 10839591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Update on the neurological consequences of HIV-1 infection (2006)].
    Tardieu M
    Rev Neurol (Paris); 2006 Jan; 162(1):19-21. PubMed ID: 16446620
    [No Abstract]   [Full Text] [Related]  

  • 29. Recurrent cerebrospinal fluid escape in an HIV-1-infected patient receiving antiretroviral therapy.
    Martins J; Santos E; Salgado P; Maia L; Dias D; Marta M; França M
    AIDS; 2016 Apr; 30(7):1143-4. PubMed ID: 27028145
    [No Abstract]   [Full Text] [Related]  

  • 30. Detection of TT virus in HIV-1 exposed but uninfected individuals and in HIV-1 infected patients and its influence on CD4+ lymphocytes and viral load.
    Nasser TF; Brajão de Oliveira K; Reiche EM; Amarante MK; Pelegrinelli Fungaro MH; Watanabe MA
    Microb Pathog; 2009 Jul; 47(1):33-7. PubMed ID: 19409976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is the glass three-quarters full or one-quarter empty?
    McArthur JC; Letendre SL
    J Infect Dis; 2006 Dec; 194(12):1628-31. PubMed ID: 17109332
    [No Abstract]   [Full Text] [Related]  

  • 32. The incidence of and risk factors for HIV-associated cognitive-motor complex among patients on HAART.
    Jevtović Dj; Vanovac V; Veselinović M; Salemović D; Ranin J; Stefanova E
    Biomed Pharmacother; 2009 Sep; 63(8):561-5. PubMed ID: 19026516
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Which helminth coinfections really affect HIV disease progression?
    Modjarrad K
    AIDS; 2009 Jan; 23(2):276-7; author reply 277-8. PubMed ID: 19098502
    [No Abstract]   [Full Text] [Related]  

  • 34. Neurosymptomatic cerebrospinal fluid escape in HIV-2: a case report.
    Kulkarni V; Kulkarni R; Parchure R
    Int J STD AIDS; 2018 Jun; 29(7):726-728. PubMed ID: 29251118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measuring the "viral load" in cerebrospinal fluid in human immunodeficiency virus infection: window into brain infection?
    Price RW; Staprans S
    Ann Neurol; 1997 Nov; 42(5):675-8. PubMed ID: 9392565
    [No Abstract]   [Full Text] [Related]  

  • 36. Does the human immunodeficiency virus (HIV) RNA concentration in cerebrospinal fluid help clinicians diagnose or understand HIV-induced neurological disease?
    Daar ES
    Clin Infect Dis; 1998 May; 26(5):1074-5. PubMed ID: 9597228
    [No Abstract]   [Full Text] [Related]  

  • 37. Central nervous system antiretroviral efficacy in HIV infection: a qualitative and quantitative review and implications for future research.
    Cysique LA; Waters EK; Brew BJ
    BMC Neurol; 2011 Nov; 11():148. PubMed ID: 22107790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dementia trial underway.
    AIDS Patient Care STDS; 2000 Apr; 14(4):227. PubMed ID: 10806651
    [No Abstract]   [Full Text] [Related]  

  • 39. HIV encephalitis related to the development of a discordant resistant virus in CNS.
    Pérez-Rodríguez MT; Sousa A; Martínez-Cueto P; Ocampo A
    Clin Microbiol Infect; 2015 Aug; 21(8):e59-60. PubMed ID: 25980354
    [No Abstract]   [Full Text] [Related]  

  • 40. Significant differences in DNA viral load between HIV-1 and HIV-2 infected patients.
    Gueudin M; Bénard A; Chêne G; Matheron S; Simon F
    AIDS; 2008 Jul; 22(12):1519-20. PubMed ID: 18614877
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.